Cytokinetics | Kortsiktig Gjeld



Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Cytokinetics USD 179.67M 69.86M 2024-12
Eisai JPY 381.62B 54.78B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Exelixis USD 403.77M 9.42M 2025-01
Geron USD 88.3M 49.64M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Intra Cellular Therapies USD 205.7M 39.59M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 30.03B 5.82B 2024-06



Cytokinetics Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.